FyMed, Inc.

Press Releases
biotechnology company

FyMed Expands Its Discovery and Drug Development Plans Through Innovative Strategies in Precision Medicine

FyMed, Inc. today announced strategic and operational expansion plans following the successful completion of major preclinical drug studies utilizing innovative companion diagnostic and prognostic technologies in precision medicine.
Read More...

FyMed Reinforces Its Drug Development Pipeline With Novel Strategies in Precision Medicine

FyMed, Inc., a pharmaceutical company utilizing proprietary methodologies in evidence-based medicine for drug discoveries recently announced plans for the strategic and operational reinforcements of their drug development pipeline through innovative approaches in precision medicine. Read More...